NCT03478475

Vitamin D Supplementation and and Glycemic Indexes

Completed NA Last updated 29 March 2018

What this trial tests

NA trial testing cholecalciferol (Euro-Pharm International, Canada) in Deficiency, Vitamin D in 115 participants. Completed in 19 September 2015.

Timeline

2 July 2015

Primary endpoint
19 September 2015

19 September 2015

Quick facts

Lead sponsor	Université d'Auvergne
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	115
Start date	2 July 2015
Primary completion	19 September 2015
Estimated completion	19 September 2015

Drugs / interventions tested

• cholecalciferol (Euro-Pharm International, Canada)
• Placebo

Conditions studied

• Deficiency, Vitamin D — all drugs for Deficiency, Vitamin D →
• Insulin Resistance — all drugs for Insulin Resistance →

Sponsor

Université d'Auvergne

Who can join

65 and older, any sex, with Deficiency, Vitamin D or Insulin Resistance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Age affect insulin sensitivity and the metabolism, and vitamin D status was shown to have a correlation with markers of insulin resistance. That's why, we aimed in our trial to study the effect of vitamin D supplementation on glycemic markers and index of insulin resistance.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Effect of Vitamin D Treatment on Glucose Homeostasis and Metabolism in Lebanese Older Adults: A Randomized Controlled Trial.
   El Hajj C, Chardigny JM, Boirie Y, Yammine K, et al · · 2018 · cited 15× · PMID 30379314 · DOI 10.1007/s12603-018-1083-8